DOSE-DEPENDENT ENHANCING EFFECT OF PHENOBARBITAL ON HEPATOCARCINOGENESIS INITIATED BY DIETHYLNITROSAMINE IN THE RAT
- 1 January 1981
- journal article
- research article
- Vol. 72 (1) , 170-173
Abstract
Sequential feeding of various dose levels of phenobarbital (PB) after diethylnitrosamine (DENA) administration revealed that the enhancing effect of PB on hepatocarcinogenesis was dose-dependent. The highest dose level of PB, 0.2% in the diet, greatly enhanced the formation of tumors > 5 mm in diameter. Tumors obtained in the 0.2% PB feeding group were more numerous and larger in size than those in the 0.01, 0.05 and 0.1% PB feeding groups. Although it took longer, the enhancing effect of 0.01% PB feeding was evident when DENA had been administered for 3 wk, while the same dose level of PB clearly enhanced hepatocarcinogenesis when the carcinogen had been given for 5 wk.This publication has 6 references indexed in Scilit:
- Enhancement of Rat Hepatocellular-Altered Foci by the Liver Tumor Promoter Phenobarbital: Evidence That Foci Are Precursors of Neoplasms and That the Promoter Acts on Carcinogen-Induced Lesions23JNCI Journal of the National Cancer Institute, 1978
- ENHANCING EFFECT OF PHENOBARBITAL ON DEVELOPMENT OF ENZYME-ALTERED ISLANDS AND HEPATOCELLULAR CARCINOMAS INITIATED BY 3'-METHYL-4-(DIMETHYLAMINO)AZOBENZENE OR DIETHYLNITROSAMINE1978
- ENHANCEMENT OF AZO-DYE HEPATOCARCINOGENESIS WITH DIETARY PHENOBARBITAL IN RATS1977
- EFFECTS OF VARYING ONSET AND DURATION OF EXPOSURE TO PHENOBARBITAL ON ITS ENHANCEMENT OF 2-ACETYLAMINOFLUORENE-INDUCED HEPATIC TUMORIGENESIS1977
- PHENOBARBITAL-INDUCED FINE STRUCTURAL CHANGES IN RAT LIVER1966
- Puromycin Inhibition of Enzyme Induction by 3-Methylcholanthrene and PhenobarbitalJournal of Biological Chemistry, 1963